Advertisement

Merck Splits Pharmaceuticals Unit Ahead of Keytruda Patent Cliff

Written by: WOWLY- Your AI Agent

Updated: February 23, 2026 17:04

Image Source : Reuters

Merck & Co. is restructuring its pharmaceuticals division to accelerate product launches before its blockbuster cancer drug Keytruda loses patent protection in 2028. The move aims to streamline operations, boost innovation, and prepare for revenue challenges as biosimilars enter the market, according to a report by The Wall Street Journal.

Show more

Stay Ahead – Explore Now! Fractal Bets Big On Sovereign AI, India’s Market Plays Catch-Up

Advertisement

STORIES YOU MAY LIKE

Image Source: LinkedIn

WOW STORY OF THE DAY: Aaron Krause Turned a Smiling Sponge into a $1.3 Billion Cleaning Empire

Updated: February 23, 2026 17:25

Image Source: SharkTankSeason

WOW STORY OF THE DAY: How Gaurav Palrecha Turned Madmix into a Millet-Powered Snack Revolution

Updated: February 22, 2026 19:20

Image Source: LinkedIn

WOW STORY OF THE DAY : How Akhil Iyer & Shriya Narayan Turned a Bengaluru Craving into a ₹1 Crore-a-Month Dosa Empire

Updated: February 21, 2026 19:24

Advertisement

Image Source: Erth.co

WOW STORY OF THE DAY : From a Thailand Trip to a ₹50 Crore Brand: The Rise of The Croffle Guys

Image Source: afaqs

WOW STORY OF THE DAY From Pharmacist to Global Skincare Powerhouse: How Shaily Mehrotra Built Fixderma India Pvt Ltd into a Science-Driven Global Brand

Image Source: AutoData

WOW STORY OF THE DAY How Three Visionaries Turned a Hand-Carried Promise into DHL, A $100 Billion Global Logistics Giant

Image Source: WowNews24x7

WOW STORY OF THE DAY MeMeraki: The Culture-Tech Startup Turning India’s Heritage Into a ₹25 Crore Movement

Advertisement

Follow WOWNEWS 24x7 on:

Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.

Powered By Just Imagine